The progression of other tumor types was positively correlated with PRL-3 expression[14], suggesting that PRL-3 is a molecular marker for metastatic tumor cells and could be an important target for anticancer therapeutics[5],[15],[16]. Here, PTP4A3 is linked to neoplasm.